308 34. Ryu JK, Kim J, Choi SH et al (2002) ATP-induced in vivo neurotoxicity in the rat striatum via P2 receptors. Neuroreport 13: 1611–1615 35. Kharlamov A, Jones SC, Kim DK (2002) Suramin reduces infarct volume in a model of focal brain ischemia in rats. Exp Brain Res 147:353–359 36. Melani A, Amadio S, Gianfriddo M et al (2006) P2X7 receptor modulation on microglial cells and reduction of brain infarct caused by middle cerebral artery occlusion in rat. J Cereb Blood Flow Metab 26:974–982 37. Lammer A, Gunther A, Beck A et al (2006) Neuroprotective effects of the P2 receptor antagonist PPADS on focal cerebral ischaemia-induced injury in rats. Eur J Neurosci 23:2824–2828 38. Marrelli SP, Khorovets A, Johnson TD et al (1999) P2 purinoceptor-mediated dilations in the rat middle cerebral artery after ischemia-reperfusion. Am J Physiol 276:H33–H41 39. Lahiri P, Chaudhuri U, Chattopadhyay A et al (2005) Structural insights in platelet receptor synergism-antiplatelet therapy in post-ischemic cerebrovascular events. Blood Cells Mol Dis 34:248–256 40. Ziegler S, Schillinger M, Funk M et al (2005) Association of a functional polymorphism in the clopidogrel target receptor gene, P2Y12, and the risk for ischemic cerebrovascular events in patients with peripheral artery disease. Stroke 36:1394–1399 41. Neary JT (2000) Trophic actions of extracellular ATP: gene expression profiling by DNA array analysis. J Auton Nerv Syst 81: 200–204 42. Rathbone MP, DeForge S, Deluca B et al (1992) Purinergic stimulation of cell division and differentiation: mechanisms and pharmacological implications. Med Hypotheses 37:213–219 43. Franke H, Illes P (2006) Involvement of P2 receptors in the growth and survival of neurons in the CNS. Pharmacol Ther 109:297–324 44. Mishrda SK, Braun N, Shukla V et al (2006) Extracellular nucleotide signaling in adult neural stem cells: synergism with growth factor-mediated cellular proliferation. Development 133: 675–684 45. Kawano S, Otsu K, Kuruma A et al (2006) ATP autocrine/ paracrine signaling induces calcium oscillations and NFAT activation in human mesenchymal stem cells. Cell Calcium 39:313–324 46. Coppi E, Pugliese AM, Urbani S et al (2007) ATP modulates cell proliferation and elicits two different electrophysiological responses in human mesenchymal stem cells. Stem Cells 25:1840–1849 47. Scholzke MN, Schwaninger M (2007) Transcriptional regulation of neurogenesis: potential mechanisms in cerebral ischemia. J Mol Med 85:577–588 48. Latini S, Pedata F (2001) Adenosine in the central nervous system: release mechanisms and extracellular concentrations. J Neurochem 79:463–484 49. von Lubitz DK, Lin RC, Bischofberger N et al (1999) Protection against ischemic damage by adenosine amine congener, a potent and selective adenosine A1 receptor agonist. Eur J Pharmacol 369: 313–317 50. Yawo H, Chuhma N (1993) Preferential inhibition of omega- conotoxin-sensitive presynaptic Ca2+ channels by adenosine autoreceptors. Nature 365:256–258 51. Wu LG, Saggau P (1994) Adenosine inhibits evoked synaptic transmission primarily by reducing presynaptic calcium influx in area CA1 of hippocampus. Neuron 12:1139–1148 52. Prince DA, Stevens CF (1992) Adenosine decreases neurotrans- mitter release at central synapses. Proc Natl Acad Sci USA 89:8586–8590 53. Fredholm BB, Dunwiddie TV (1988) How does adenosine inhibit transmitter release? Trends Pharmacol Sci 9:130–134 Purinergic Signalling (2007) 3:299–310 54. Burke SP, Nadler JV (1988) Regulation of glutamate and aspartate release from slices of the hippocampal CA1 area: effects of adenosine and baclofen. J Neurochem 51:1541– 1551 55. Corradetti R, Lo CG, Moroni F et al (1984) Adenosine decreases aspartate and glutamate release from rat hippocampal slices. Eur J Pharmacol 104:19–26 56. Lupica CR, Proctor WR, Dunwiddie TV (1992) Presynaptic inhibition of excitatory synaptic transmission by adenosine in rat hippocampus: analysis of unitary EPSP variance measured by whole-cell recording. J Neurosci 12:3753–3764 57. Takigawa T, Alzheimer C (1999) G protein-activated inwardly rectifying K+ (GIRK) currents in dendrites of rat neocortical pyramidal cells. J Physiol 517(Pt 2):385–390 58. Takigawa T, Alzheimer C (2002) Phasic and tonic attenuation of EPSPs by inward rectifier K+ channels in rat hippocampal pyramidal cells. J Physiol 539:67–75 59. Latini S, Bordoni F, Corradetti R et al (1999) Effect of A2A adenosine receptor stimulation and antagonism on synaptic depres- sion induced by in vitro ischaemia in rat hippocampal slices. Br J Pharmacol 128:1035–1044 60. Latini S, Bordoni F, Pedata F et al (1999) Extracellular adenosine concentrations during in vitro ischaemia in rat hippocampal slices. Br J Pharmacol 127:729–739 61. Moore KA, Nicoll RA, Schmitz D (2003) Adenosine gates synaptic plasticity at hippocampal mossy fiber synapses. Proc Natl Acad Sci USA 100:14397–14402 62. Pedata F, Pepeu G, Spignoli G (1984) Biphasic effect of methyl- xanthines on acetylcholine release from electrically-stimulated brain slices. Br J Pharmacol 83:69–73 63. Latini S, Pazzagli M, Pepeu G et al (1996) A2 adenosine receptors: their presence and neuromodulatory role in the central nervous system. Gen Pharmacol 27:925–933 64. Sebastiao AM, Ribeiro JA (1996) Adenosine A2 receptor-mediated excitatory actions on the nervous system. Prog Neurobiol 48:167– 189 65. Spignoli G, Pedata F, Pepeu G (1984) A1 and A2 adenosine receptors modulate acetylcholine release from brain slices. Eur J Pharmacol 97:341–342 66. Cunha RA, Johansson B, Fredholm BB et al (1995) Adenosine A2A receptors stimulate acetylcholine release from nerve termi- nals of the rat hippocampus. Neurosci Lett 196:41–44 67. Cunha RA, Johansson B, van der Ploeg I et al (1994) Evidence for functionally important adenosine A2a receptors in the rat hippocampus. Brain Res 649:208–216 68. Dixon AK, Widdowson L, Richardson PJ (1997) Desensitisation of the adenosine A1 receptor by the A2A receptor in the rat striatum. J Neurochem 69:315–321 69. Stone TW, Nikbakth M-R, O’Kane EM (2004) Adenosine and purines. In: Riedel G, Platt B (eds) From messengers to molecules: memories are made of these. Kluwer Academic/Plenum, New York, p 196–223 70. Popoli P, Betto P, Reggio R et al (1995) Adenosine A2A receptor stimulation enhances striatal extracellular glutamate levels in rats. Eur J Pharmacol 287:215–217 71. Corsi C, Melani A, Bianchi L et al (1999) Striatal A2A adenosine receptor differentially regulate spontaneous and K+-evoked glutamate release in vivo in young and aged rats. Neuroreport 10:687–691 72. Corsi C, Melani A, Bianchi L et al (2000) Striatal A2A adenosine receptor antagonism differentially modifies striatal glutamate outflow in vivo in young and aged rats. Neuroreport 11:2591–2595 73. Ross GW, Abbott RD, Petrovitch H et al (2000) Association of coffee and caffeine intake with the risk of Parkinson disease. JAMA 283:2674–2679